Defining prior therapy in myelodysplastic syndromes and criteria for relapsed and refractory disease: implications for clinical trial design and enrollment (Q37372798)
Jump to navigation
Jump to search
scientific article published on 15 July 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Defining prior therapy in myelodysplastic syndromes and criteria for relapsed and refractory disease: implications for clinical trial design and enrollment |
scientific article published on 15 July 2009 |
Statements
1 reference
Defining prior therapy in myelodysplastic syndromes and criteria for relapsed and refractory disease: implications for clinical trial design and enrollment (English)
1 reference
David P Steensma
1 reference
Mikkael A Sekeres
1 reference
15 July 2009
1 reference
1 reference
2575-2580
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference